GFC Life Science Grants 20,000 Stock Options to Key Personnel; Minor Dilution of 0.38%
The company's board resolved to grant a total of 20,000 stock options to two key personnel including an unregistered executive and an advisory committee member to encourage long-term retention and enhance corporate value.
The exercise price is set at 5,755 KRW, a 4.7% discount to the current stock price of 6,040 KRW. Options are exercisable from two years after grant for a three-year period.
This grant represents only 0.38% of total outstanding shares, resulting in minimal dilution risk for existing shareholders.
[AI Summary]This stock option grant is a routine retention tool with negligible dilution and no significant impact on shareholder value.